OXFORD--Wyeth-Ayerst Research has signed a deal with Oxford Molecular Group to license and install Oxford's RS3 Discovery client/server information management system enterprise-wide. According to Oxford, the pharmaceutical company will use the system for chemical registration, structure and substructure searching, and integrating biological assay data through a common Oracle-RS3 Discovery server.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.